Unreported antiretroviral use by HIV-1-infected participants enrolling in a prospective research study.
*Department of Epidemiology, University of Washington, Seattle, WA †Division of Pharmacotherapy and Experimental Therapeutics, Echelman School of Pharmacy, University of North Carolina, Chapel Hill, NC Departments of ‡Global Health; §Medicine, University of Washington, Seattle, WA ‖Department of Medicine, Indiana University, Indianapolis, IN ¶Department of Immunology and Infectious Disease, Harvard School of Public Health, Harvard University, Cambridge, MA #Perinatal HIV Research Unit, University of Witwatersrand, Johannesburg, Republic of South Africa **Vaccine and Infectious Disease Institute, Fred Hutchinson Cancer Research Center, Seattle, WA ††Department of Pediatrics, University of Washington, Seattle, WA ‡‡Wits Reproductive Health and HIV Institute, University of Witwatersrand, Johannesburg, Republic of South Africa §§Department of Obstetrics and Gynecology, University of Nairobi and Kenyatta National Hospital, Nairobi, Kenya.
Erin M
EM
Kahle
Angela
A
Kashuba
Jared M
JM
Baeten
Kenneth H
KH
Fife
Connie
C
Celum
Andrew
A
Mujugira
Max
M
Essex
Guy
G
De Bruyn
Anna
A
Wald
Deborah
D
Donnell
Grace
G
John-Stewart
Sinead
S
Delany-Moretlwe
Nelly R
NR
Mugo
Carey
C
Farquhar
Jairam R
JR
Lingappa
D000293:Adolescent; D000328:Adult; D019380:Anti-HIV Agents / Q000627:therapeutic use*; D004363:Drug Utilization / Q000706:statistics & numerical data*; D005260:Female; D015658:HIV Infections / Q000188:drug therapy* / Q000821:virology; D015497:HIV-1 / Q000302:isolation & purification; D006801:Humans; D008297:Male; D011446:Prospective Studies; D055815:Young Adult
D019380:Anti-HIV Agents